非酒精性脂肪性肝炎(NASH)曾经在全球范围内出现,而且有效的疗法,尤其是针对肝纤维化的疗法可以明显改善患者预后;日前来自日本的研究人员通过研究鉴别出了一种激素介导的机制,其或许能够限制纤维化相关的非酒精性脂肪性肝炎和肝硬化的发生,相关研究刊登于国际杂志Scientific Reports上,该研究或为后期开发相应疾病的新型疗法提供新的思路。 Non-alcoholic steatohepatitis (NASH) has been around the world, and effective therapies, especially for the treatment of liver fibrosis can significantly improve the prognosis of patients; recently from Japan researchers identified a hormone mediated Mechanisms that may limit fibrosis-related Nonalcoholic steatohepatitis and cirrhosis are published in Scientific Reports, a study published in the International Journal, which could provide new insights into the development of new therapies for later disease development.